ICU Medical Inc (ICUI)
95.70
+1.17
(+1.24%)
USD |
NASDAQ |
Apr 26, 11:07
ICU Medical Revenue (Quarterly): 587.86M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 587.86M |
| September 30, 2023 | 553.31M |
| June 30, 2023 | 549.31M |
| March 31, 2023 | 568.65M |
| December 31, 2022 | 578.01M |
| September 30, 2022 | 597.86M |
| June 30, 2022 | 561.00M |
| March 31, 2022 | 543.12M |
| December 31, 2021 | 340.52M |
| September 30, 2021 | 336.06M |
| June 30, 2021 | 321.68M |
| March 31, 2021 | 318.05M |
| December 31, 2020 | 320.45M |
| September 30, 2020 | 318.57M |
| June 30, 2020 | 303.38M |
| March 31, 2020 | 328.61M |
| December 31, 2019 | 315.52M |
| September 30, 2019 | 307.47M |
| June 30, 2019 | 312.28M |
| March 31, 2019 | 330.93M |
| December 31, 2018 | 340.38M |
| September 30, 2018 | 327.17M |
| June 30, 2018 | 360.46M |
| March 31, 2018 | 372.03M |
| December 31, 2017 | 370.12M |
| Date | Value |
|---|---|
| September 30, 2017 | 343.24M |
| June 30, 2017 | 331.51M |
| March 31, 2017 | 247.74M |
| December 31, 2016 | 95.69M |
| September 30, 2016 | 97.11M |
| June 30, 2016 | 96.72M |
| March 31, 2016 | 89.86M |
| December 31, 2015 | 90.39M |
| September 30, 2015 | 86.02M |
| June 30, 2015 | 83.78M |
| March 31, 2015 | 81.48M |
| December 31, 2014 | 79.90M |
| September 30, 2014 | 77.46M |
| June 30, 2014 | 78.68M |
| March 31, 2014 | 73.23M |
| December 31, 2013 | 77.94M |
| September 30, 2013 | 82.82M |
| June 30, 2013 | 78.66M |
| March 31, 2013 | 74.30M |
| December 31, 2012 | 82.67M |
| September 30, 2012 | 81.40M |
| June 30, 2012 | 77.28M |
| March 31, 2012 | 75.51M |
| December 31, 2011 | 76.47M |
| September 30, 2011 | 76.46M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
303.38M
Minimum
Jun 2020
597.86M
Maximum
Sep 2022
424.30M
Average
336.06M
Median
Sep 2021
Revenue (Quarterly) Benchmarks
| Integer Holdings Corp | 413.15M |
| LeMaitre Vascular Inc | 48.88M |
| ResMed Inc | 1.163B |
| UFP Technologies Inc | 101.50M |
| Perspective Therapeutics Inc | -5.239M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.15M |
| Total Expenses (Quarterly) | 593.30M |
| EPS Diluted (Quarterly) | -0.71 |
| Enterprise Value | 3.656B |
| Gross Profit Margin (Quarterly) | 29.19% |
| Profit Margin (Quarterly) | -2.92% |
| Earnings Yield | -1.29% |
| Operating Earnings Yield | 2.07% |
| Normalized Earnings Yield | -0.2447 |